Pascale Schwab1, Harlan Sayles2, Debra Bergman2, Grant W Cannon3, Kaleb Michaud4, Ted R Mikuls2, Jennifer Barton1. 1. VA Portland Health Care System and Oregon Health and Science University, Portland. 2. VA Nebraska-Western Iowa Health Care System, and Nebraska Arthritis Outcomes Research Center, University of Nebraska Medical Center, Omaha. 3. VA Salt Lake City Health Care System and University of Utah School of Medicine, Salt Lake City. 4. VA Nebraska-Western Iowa Health Care System, Nebraska Arthritis Outcomes Research Center, University of Nebraska Medical Center, Omaha, and the National Data Bank for Rheumatic Diseases, Wichita, Kansas.
Abstract
OBJECTIVE: Many veterans enrolled in Veterans Affairs (VA) health care systems also receive care through other health care systems. Both VA and non-VA health care use must therefore be considered when conducting research in this population. This study characterized dual-care utilization in veterans with rheumatoid arthritis (RA) and explored associations with RA disease activity. METHODS: Through a questionnaire mailed to RA patients at 3 VA sites, veterans reported medical services by non-VA primary care and subspecialty providers, comorbidities, non-VA medications, and hospitalizations. Disease Activity Score in 28 joints (DAS28) and Multidimensional Health Assessment Questionnaire (MD-HAQ) scores were recorded during VA clinic visits, and respondent groups were compared. RESULTS: Of the 510 participants surveyed, 318 (62%) responded. Respondents were older (ages 69 versus 66 years; P = 0.006), more likely nonsmokers (80% versus 67%; P = 0.001), and had lower disease activity (DAS28 3.3 versus 3.8; P < 0.001, MD-HAQ 0.8 versus 0.9; P = 0.01) than nonrespondents (n = 192 [38%]). The respondents with a non-VA provider (n = 130 [41%]) were older (71 versus 68 years; P = 0.001) and had more education (14 versus 13 years; P = 0.021) than nondual-care users. Only 6% of respondents reported having a non-VA rheumatologist, with 2% receiving a non-VA prescribed biologic agent or disease-modifying antirheumatic drug. CONCLUSION: In this study, VA beneficiaries with RA had lower dual-care utilization than previously reported for the general VA population, with few patients receiving dual rheumatology care or non-VA RA medications. This survey suggests that most US veterans with RA who access VA care use the VA as their primary source of arthritis care.
OBJECTIVE: Many veterans enrolled in Veterans Affairs (VA) health care systems also receive care through other health care systems. Both VA and non-VA health care use must therefore be considered when conducting research in this population. This study characterized dual-care utilization in veterans with rheumatoid arthritis (RA) and explored associations with RA disease activity. METHODS: Through a questionnaire mailed to RApatients at 3 VA sites, veterans reported medical services by non-VA primary care and subspecialty providers, comorbidities, non-VA medications, and hospitalizations. Disease Activity Score in 28 joints (DAS28) and Multidimensional Health Assessment Questionnaire (MD-HAQ) scores were recorded during VA clinic visits, and respondent groups were compared. RESULTS: Of the 510 participants surveyed, 318 (62%) responded. Respondents were older (ages 69 versus 66 years; P = 0.006), more likely nonsmokers (80% versus 67%; P = 0.001), and had lower disease activity (DAS28 3.3 versus 3.8; P < 0.001, MD-HAQ 0.8 versus 0.9; P = 0.01) than nonrespondents (n = 192 [38%]). The respondents with a non-VA provider (n = 130 [41%]) were older (71 versus 68 years; P = 0.001) and had more education (14 versus 13 years; P = 0.021) than nondual-care users. Only 6% of respondents reported having a non-VA rheumatologist, with 2% receiving a non-VA prescribed biologic agent or disease-modifying antirheumatic drug. CONCLUSION: In this study, VA beneficiaries with RA had lower dual-care utilization than previously reported for the general VA population, with few patients receiving dual rheumatology care or non-VA RA medications. This survey suggests that most US veterans with RA who access VA care use the VA as their primary source of arthritis care.
Authors: Huanguang Jia; Yu Zheng; Dean M Reker; Diane C Cowper; Samuel S Wu; W Bruce Vogel; Gail C Young; Pamela W Duncan Journal: Stroke Date: 2006-12-28 Impact factor: 7.914
Authors: Lisa A Davis; Emily Whitfield; Grant W Cannon; Roger K Wolff; Dannette S Johnson; Andreas M Reimold; Gail S Kerr; J Steuart Richards; Ted R Mikuls; Liron Caplan Journal: Rheumatology (Oxford) Date: 2014-06 Impact factor: 7.580
Authors: Denise M Hynes; Kristin Koelling; Kevin Stroupe; Noreen Arnold; Katherine Mallin; Min-Woong Sohn; Frances M Weaver; Larry Manheim; Linda Kok Journal: Med Care Date: 2007-03 Impact factor: 2.983
Authors: K Michaud; T R Mikuls; S E Call; A M Reimold; R Hooker; G S Kerr; J S Richards; L Caplan; G W Cannon Journal: Clin Exp Rheumatol Date: 2009 Jul-Aug Impact factor: 4.473
Authors: Ted R Mikuls; Karen A Gould; Kimberly K Bynoté; Fang Yu; Tricia D Levan; Geoffrey M Thiele; Kaleb D Michaud; James R O'Dell; Andreas M Reimold; Roderick Hooker; Liron Caplan; Dannette S Johnson; Gail Kerr; J Steuart Richards; Grant W Cannon; Lindsey A Criswell; Janelle A Noble; S Louis Bridges; Laura Hughes; Peter K Gregersen Journal: Arthritis Res Ther Date: 2010-11-18 Impact factor: 5.156
Authors: Matthew L Maciejewski; Mark Perkins; Yu-Fang Li; Michael Chapko; John C Fortney; Chuan-Fen Liu Journal: BMC Health Serv Res Date: 2007-04-18 Impact factor: 2.655
Authors: Caroline B McCulley; Jennifer L Barton; Grant W Cannon; Brian C Sauer; Chia Chen Teng; Michael D George; Liron Caplan; Bryant R England; Ted R Mikuls; Joshua F Baker Journal: Clin Exp Rheumatol Date: 2018-11-07 Impact factor: 4.473
Authors: Yasir Ahmed Mohammed Elhadi; Abdelmuniem Ahmed; Ramy Mohamed Ghazy; Elhadi B Salih; Osman S Abdelhamed; Ramy Shaaban; Hammad Mohamed Hammad Mohamed; Alanood Elnaeem Mohamed; Noha Ahmed El Dabbah; Ashraf Ahmed Zaher Zaghloul Journal: Healthcare (Basel) Date: 2022-03-27
Authors: Michael D George; Brian C Sauer; Chia-Chen Teng; Grant W Cannon; Bryant R England; Gail S Kerr; Ted R Mikuls; Joshua F Baker Journal: J Rheumatol Date: 2018-10-01 Impact factor: 4.666
Authors: Grant W Cannon; Alan R Erickson; Chia-Chen Teng; Tina Huynh; Sharon Austin; Sally W Wade; Bradley S Stolshek; David H Collier; Alex Mutebi; Brian C Sauer Journal: Rheumatol Adv Pract Date: 2019-05-28
Authors: Rebecca Kartje; Brian E Dixon; Ashley L Schwartzkopf; Vivian Guerrero; Kimberly M Judon; Joanne C Yi; Kenneth Boockvar Journal: J Am Board Fam Med Date: 2021 Mar-Apr Impact factor: 2.657
Authors: Bryant R England; Punyasha Roul; Yangyuna Yang; Andre C Kalil; Kaleb Michaud; Geoffrey M Thiele; Brian C Sauer; Joshua F Baker; Ted R Mikuls Journal: Arthritis Rheumatol Date: 2021-10-19 Impact factor: 15.483
Authors: Namrata Singh; Yubo Gao; Elizabeth Field; Brian K Link; Noel Weiss; Jeffrey R Curtis; Charles F Lynch; Mary Vaughan-Sarrazin Journal: RMD Open Date: 2020-07